LBPH Live signals | Maximize Profits with Getagraph.com

BUY 157855 min ago

@ $20.40

Issued: 14 Feb 2024 @ 12:18

Return: -7.50%

Previous signal: Feb 13 - 15:23

Previous signal: Sell

Return: 0.94 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	558 225
Average Volume	399 728
Market Cap	733.67M
EPS	$0 ( 2024-05-14 )
Next earnings date	( $-0.450 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.39
ATR14	$0.0390 (0.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-23	Sekhri Paul J	Buy	22 500	Stock Option (Right to Buy)
2024-05-23	Schneider Phillip M	Buy	22 500	Stock Option (Right to Buy)
2024-05-23	Lynch Casey	Buy	22 500	Stock Option (Right to Buy)
2024-05-23	Le Goff Corinne	Buy	22 500	Stock Option (Right to Buy)
2024-05-23	Aurentz Vincent	Buy	22 500	Stock Option (Right to Buy)

INSIDER POWER
-59.34
Last 53 transactions
Buy: 2 292 830 \| Sell: 4 964 362

Volume Correlation

Long: 0.25 (neutral)

Short: -0.66 (moderate negative)

Signal:(64.058) Neutral

Longboard Correlation

10 Most Positive Correlations

10 Most Negative Correlations
ALVR	-0.853

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Longboard Correlation - Currency/Commodity

0.00
( neutral )

-0.01
( neutral )

0.00
( neutral )

0.23
( neutral )

-0.03
( neutral )

-0.29
( neutral )

Longboard Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-5 000.00 (0.00 %)
EPS:	$-2.39

FY	2023
Revenue:	$0
Gross Profit:	$-5 000.00 (0.00 %)
EPS:	$-2.39

FY	2022
Revenue:	$0
Gross Profit:	$-5 000.00 (0.00 %)
EPS:	$-2.51

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.648

Financial Reports:

No articles found.

Longboard Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Longboard

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.